Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > O Yeah !! BUC EUA News Very Soon - Hope So !!!

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Sep 21, 2021 7:03pm

144 Views

Post# 33896382

RE:RE:O Yeah !! BUC EUA News Very Soon - Hope So !!!

There are 20 other trials at phase 3 in North America and 100 worldwide.

This is a mushroom play. MF couldn't push Buc through the FDA if it could get cool88 laid and a full head of hair.

Joe455 wrote:

cool888 wrote: Candy -

Pfizer's Ritonavir trial primary completion moved to later November - study completion moved to April 2022.

https://clinicaltrials.gov/ct2/history/NCT04960202?A=6&B=7&C=merged#StudyPageTop

M -

clinical trials take time even when a company has pretty much unlimited money. This shows even more clearly how incredible is the job that MF and RVV are doing.

Lots of upside from here.